Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl E Allen

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
Plos One|March 11, 2011
The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesisShujun Liu, Francesca Madiai, Kevin V Hackshaw, et al.
Cancers|November 27, 2024
Tumor-Associated Edema in Children with Kaposi Sarcoma: 14 Years' Experience at Kamuzu Central Hospital, Lilongwe, MalawiFatsani Rose Manase, Allison Silverstein, William Kamiyango, et al.
Pediatric Blood & Cancer|April 24, 2012
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumabRebecca A Marsh, Carl E Allen, Kenneth L McClain, et al.
Frontiers in Oncology|June 28, 2024
Rapid gene fusion testing using the NanoString nCounter platform to improve pediatric leukemia diagnoses in Sub-Saharan AfricaJulie M Gastier-Foster, Fredrick Lutwama, Olive Mbabazi, et al.
Blood|October 19, 2020
Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCHAmel Sengal, Jessica Velazquez, Meryl Hahne, et al.
British Journal of Haematology|March 19, 2024
Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosisVivekanudeep Karri, Howard Lin, Jessica Velazquez, et al.
Blood Advances|January 1, 2024
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group studyBirte Wistinghausen, Keri Toner, Donald A Barkauskas, et al.
HIV Medicine|October 11, 2021
Long-term outcomes for children and adolescents with Kaposi sarcomaAllison Silverstein, William Kamiyango, Jimmy Villiera, et al.
Blood|September 23, 2017
A genome-wide association study of LCH identifies a variant in <i>SMAD6</i> associated with susceptibilityErin C Peckham-Gregory, Rikhia Chakraborty, Michael E Scheurer, et al.
Pediatric Blood & Cancer|November 3, 2016
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosisRobert J Arceci, Carl E Allen, Ira J Dunkel, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
Plos One|March 11, 2011
The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesisShujun Liu, Francesca Madiai, Kevin V Hackshaw, et al.
Cancers|November 27, 2024
Tumor-Associated Edema in Children with Kaposi Sarcoma: 14 Years' Experience at Kamuzu Central Hospital, Lilongwe, MalawiFatsani Rose Manase, Allison Silverstein, William Kamiyango, et al.
Pediatric Blood & Cancer|April 24, 2012
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumabRebecca A Marsh, Carl E Allen, Kenneth L McClain, et al.
Frontiers in Oncology|June 28, 2024
Rapid gene fusion testing using the NanoString nCounter platform to improve pediatric leukemia diagnoses in Sub-Saharan AfricaJulie M Gastier-Foster, Fredrick Lutwama, Olive Mbabazi, et al.
Blood|October 19, 2020
Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCHAmel Sengal, Jessica Velazquez, Meryl Hahne, et al.
British Journal of Haematology|March 19, 2024
Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosisVivekanudeep Karri, Howard Lin, Jessica Velazquez, et al.
Blood Advances|January 1, 2024
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group studyBirte Wistinghausen, Keri Toner, Donald A Barkauskas, et al.
HIV Medicine|October 11, 2021
Long-term outcomes for children and adolescents with Kaposi sarcomaAllison Silverstein, William Kamiyango, Jimmy Villiera, et al.
Blood|September 23, 2017
A genome-wide association study of LCH identifies a variant in <i>SMAD6</i> associated with susceptibilityErin C Peckham-Gregory, Rikhia Chakraborty, Michael E Scheurer, et al.
Pediatric Blood & Cancer|November 3, 2016
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosisRobert J Arceci, Carl E Allen, Ira J Dunkel, et al.
Pageof 14